CEL-SCI Corporation (CVM -2.5%) isn't getting much of a lift today, despite its announcement...
CEL-SCI Corporation (CVM -2.5%) isn't getting much of a lift today, despite its announcement that collaborators at the National Institute of Allergy and Infectious Diseases have submitted for publication the results from efficacy studies in animals using CVM's H1N1 activated dendritic cells to treat the H1N1 bird flu virus. This work may possibly also be applicable to the new H7N9 bird flu strain currently detected in China, but no definitive statement has yet been made to that effect.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs